# The influence of washed microbiota transplantation on menstruation in female patients of childbearing age

**Authors:** Qingting Wu, Mingzhu Wang, Juan Yang, Jiangyan Wang, Shuo Feng, Shenghua Lu, Zhichu Qin, Xingxiang He, Lei Wu

PMC · DOI: 10.3389/fendo.2026.1715020 · Frontiers in Endocrinology · 2026-02-11

## TL;DR

Washed microbiota transplantation (WMT) improves quality of life, reduces depression and anxiety, and enhances gut microbiota diversity in women with menstrual disorders.

## Contribution

This study demonstrates WMT's effectiveness in improving menstrual and mental health outcomes in women of childbearing age.

## Key findings

- WMT significantly improved SF-36 scores and reduced depression and anxiety scores in female patients.
- WMT increased gut microbiota diversity and altered the abundance of specific bacterial genera.
- Menstrual disorder scores correlated with changes in quality of life and mental health metrics.

## Abstract

Menstrual disorders are closely related to the disorder of gut microbiota. This study aims to explore the impact of Washed microbiota transplantation (WMT) on the quality of life, depression and anxiety scale scores, and menstrual conditions of female patients of childbearing age.

The data of female patients of childbearing age who received WMT at the First Affiliated Hospital of Guangdong Pharmaceutical University from February 2023 to February 2025 were collected. A comparative analysis was conducted on the effects of SF-36, SDS, SAS and menstrual conditions in female patients of childbearing age before and after WMT treatment. The changes of gut microbiota before and after WMT were analyzed by 16S rRNA gene sequencing.

A total of 23 female patients of childbearing age were included in this study. WMT significantly improved the scores of GH, SF, MH, RE and VT in SF-36 of female patients of childbearing age and significantly reduced the scores of SDS and SAS (P < 0.05). The MDQ score was negatively correlated with the PF, BP, GH, VT, RE and MH scores in SF-36, and positively correlated with the SDS and SAS scores (P < 0.05). WMT enhanced the α diversity of gut microbiota in female patients of childbearing age, and the Chao1 and Shannon indices were statistically significant (P < 0.05). At the same time, the relative abundance of Dialister, Bifidobacterium, Faecalibacterium, Roseburia and Fusobacterium increases. The relative abundances of Bacteroides, Agathobacter, Prevotella, Escherichia-Shigella and Ruminococcus decreased.

WMT treatment can effectively improve the quality of life score of female patients of childbearing age and reduce the scores of depression and anxiety scales. WMT can increase the diversity and abundance of gut microbiota in female patients of childbearing age and improve menstrual conditions, which provides new ideas for future clinical treatment.

## Full-text entities

- **Genes:** IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 8836] {aka GATD10, GH}
- **Diseases:** metabolic syndrome (MESH:D024821), MH (MESH:C535694), inflammation (MESH:D007249), gastrointestinal symptoms (MESH:D012817), endometriosis (MESH:D004715), Menstrual disorders (MESH:D004412), pelvic pain (MESH:D017699), Bodily Pain (MESH:D010146), PCOS (MESH:D011085), mental system diseases (MESH:D008607), infertility (MESH:D007246), IBS (MESH:D053560), infectious pathogen infection (MESH:D007239), Crohn's disease (MESH:D003424), mental disorders (MESH:D001523), Anxiety (MESH:D001007), Blood Loss (MESH:D016063), GH (OMIM:603663), flatulence (MESH:D005414), menstrual bleeding (MESH:D008595), gynecological diseases (MESH:D005831), abdominal distension (MESH:D000007), IBD (MESH:D015212), WMT (MESH:D007674), bleeding (MESH:D006470), Depression (MESH:D003866), nausea (MESH:D009325), Irritable bowel syndrome (MESH:D043183), constipation (MESH:D003248), Distress (MESH:D012128), reproductive system diseases (MESH:D060737), -related diseases (MESH:D000077733), vomiting (MESH:D014839), premenstrual syndrome (MESH:D011293), disorders (MESH:D009358)
- **Chemicals:** saline (MESH:D012965), SDS (-), letrozole (MESH:D000077289), lactic acid (MESH:D019344), butyrate (MESH:D002087), carbohydrate (MESH:D002241), butyric acid (MESH:D020148), agarose (MESH:D012685), LPS (MESH:D008070), SDS (MESH:D012967), tryptophan (MESH:D014364), progesterone (MESH:D011374), dopamine (MESH:D004298), GABA (MESH:D005680), SCFA (MESH:D005232), 5-HT (MESH:D012701)
- **Species:** Faecalibacterium (genus) [taxon 216851], Salmonella (genus) [taxon 590], Dialister (genus) [taxon 39948], Fusobacterium (genus) [taxon 848], Mus musculus (house mouse, species) [taxon 10090], Bacteroides (genus) [taxon 816], Clostridium botulinum (species) [taxon 1491], Prevotella (genus) [taxon 838], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Lactobacillus (genus) [taxon 1578], Amedibacillus dolichus (species) [taxon 31971], Roseburia (genus) [taxon 841], Eggerthella lenta (species) [taxon 84112], Agathobacter (genus) [taxon 1766253], Ruminococcus (genus) [taxon 1263]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932191/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932191/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932191/full.md

---
Source: https://tomesphere.com/paper/PMC12932191